(Q38433378)

3 September 2017

title

Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults (English)

1 reference

3 September 2017

1 reference

1 reference

Hong-Xing Pan

1

1 reference

3 September 2017

Ying Zeng

2

1 reference

3 September 2017

Xue-Fang Song

3

1 reference

3 September 2017

Yi-Ju Zhang

4

1 reference

3 September 2017

Ke Xu

5

1 reference

3 September 2017

Zheng-Lun Liang

6

1 reference

3 September 2017

Feng-Cai Zhu

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

27 March 2014

1 reference

3 September 2017

1 reference

3 September 2017

volume

32

1 reference

3 September 2017

issue

29

1 reference

3 September 2017

page(s)

3706-3712

1 reference

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

What level of hepatitis B antibody is protective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.094

10.1016/J.VACCINE.2014.02.094

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference